GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » Market Cap

Vectorite Biomedical (ROCO:4170) Market Cap : NT$695.97 Mil (As of Jun. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vectorite Biomedical's share price for the quarter that ended in Dec. 2023 was NT$21.3. Vectorite Biomedical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 43.77 Mil. Therefore, Vectorite Biomedical's market cap for the quarter that ended in Dec. 2023 was NT$932.33 Mil.

Vectorite Biomedical's quarterly market cap stayed the same from Dec. 2022 (NT$0.00 Mil) to Jun. 2023 (NT$0.00 Mil) but then increased from Jun. 2023 (NT$0.00 Mil) to Dec. 2023 (NT$932.33 Mil).

Vectorite Biomedical's annual market cap stayed the same from Dec. 2021 (NT$0.00 Mil) to Dec. 2022 (NT$0.00 Mil) but then increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$932.33 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vectorite Biomedical's Enterprise Value for Today is NT$492.29 Mil.


Vectorite Biomedical Market Cap Historical Data

The historical data trend for Vectorite Biomedical's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectorite Biomedical Market Cap Chart

Vectorite Biomedical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 940.56 625.78 - - 932.33

Vectorite Biomedical Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 932.33

Competitive Comparison of Vectorite Biomedical's Market Cap

For the Biotechnology subindustry, Vectorite Biomedical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectorite Biomedical's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectorite Biomedical's Market Cap distribution charts can be found below:

* The bar in red indicates where Vectorite Biomedical's Market Cap falls into.



Vectorite Biomedical Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Vectorite Biomedical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$21.3*43.7714
=NT$932.33

Vectorite Biomedical's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=NT$21.3*43.7714
=NT$932.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectorite Biomedical  (ROCO:4170) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Vectorite Biomedical Market Cap Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectorite Biomedical (ROCO:4170) Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 6th Floor, Number 97, Section 1, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.

Vectorite Biomedical (ROCO:4170) Headlines

No Headlines